Back to Search
OLIVER ZIVANOVIC, MD
MD
Gynecologic Oncology Physician
NPI: 1891943262Individual
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
2674381(NY)
Research & Publications (20)
Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer.
PMID 19608640·Oncologist·2009
6-review
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.
PMID 19664812·Gynecol Oncol·2009
8-other
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
PMID 19255317·J Clin Oncol·2009
8-other
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
PMID 19110302·Gynecol Oncol·2009
8-other
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease.
PMID 18929404·Gynecol Oncol·2008
8-other
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
PMID 18774596·Gynecol Oncol·2008
8-other
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up.
PMID 18428210·Cancer·2008
8-other
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
PMID 17996927·Gynecol Oncol·2008
8-other
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
PMID 19100916·Gynecol Oncol·2009
8-other
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
PMID 19395008·Gynecol Oncol·2009
8-other
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
PMID 18755500·Gynecol Oncol·2008
8-other
Influence of preoperative MRI on the surgical management of patients with operable breast cancer.
PMID 17906928·Breast Cancer Res Treat·2008
8-other
Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer.
PMID 17466904·Lancet Oncol·2007
5-case
MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time.
PMID 16228214·Eur Radiol·2006
8-other
Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
PMID 16549623·Radiology·2006
4-observational
[The impact of the pathologist on the treatment of epithelial ovarial cancer].
PMID 18035679·Verh Dtsch Ges Pathol·2005
6-review
Patients with malignancy requiring urgent therapy: CASE 1. Central airway obstruction as first presentation of ovarian cancer.
PMID 16170186·J Clin Oncol·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10065 - Phone
- (212) 639-7033
Quick Facts
- NPI
- 1891943262
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile